Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

The burden of hepatitis C in the United States.

Kim WR.

Hepatology. 2002 Nov;36(5 Suppl 1):S30-4. Review.

PMID:
12407574
2.

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Seeff LB, Hoofnagle JH.

Clin Liver Dis. 2003 Feb;7(1):261-87. Review.

PMID:
12691470
3.

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.

Armstrong GL, Alter MJ, McQuillan GM, Margolis HS.

Hepatology. 2000 Mar;31(3):777-82.

PMID:
10706572
4.

Epidemiology of hepatitis C.

Alter MJ.

Hepatology. 1997 Sep;26(3 Suppl 1):62S-65S. Review.

PMID:
9305666
5.

Projecting future complications of chronic hepatitis C in the United States.

Davis GL, Albright JE, Cook SF, Rosenberg DM.

Liver Transpl. 2003 Apr;9(4):331-8.

6.

Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin.

Gasiorowicz M, Hurie M, Russell A, Hoxie N, Vergeront J.

WMJ. 2006 Jan;105(1):34-9.

7.

Opportunities to address the hepatitis C epidemic in the correctional setting.

Boutwell AE, Allen SA, Rich JD.

Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S367-72.

PMID:
15768350
8.

Hepatitis C: Part I. Routine serologic testing and diagnosis.

Moyer LA, Mast EE, Alter MJ.

Am Fam Physician. 1999 Jan 1;59(1):79-88, 91-2. Review.

9.

Outcome of hospital care of liver disease associated with hepatitis C in the United States.

Kim WR, Gross JB Jr, Poterucha JJ, Locke GR 3rd, Dickson ER.

Hepatology. 2001 Jan;33(1):201-6.

PMID:
11124837
10.

Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.

Lehman EM, Wilson ML.

J Viral Hepat. 2009 Sep;16(9):650-8. doi: 10.1111/j.1365-2893.2009.01115.x. Epub 2009 Apr 20.

11.

Outcome of screening for hepatitis C virus infection based on risk factors.

Mallette C, Flynn MA, Promrat K.

Am J Gastroenterol. 2008 Jan;103(1):131-7. Epub 2007 Sep 25.

PMID:
17894850
12.

The costs of not treating hepatitis C virus infection in injecting drug users in New Zealand.

Sheerin IG, Green FT, Sellman JD.

Drug Alcohol Rev. 2003 Jun;22(2):159-67.

PMID:
12850902
13.

Hepatocellular carcinoma and hepatitis C in the United States.

El-Serag HB.

Hepatology. 2002 Nov;36(5 Suppl 1):S74-83. Review.

PMID:
12407579
14.
15.

The epidemiology of hepatitis C virus infection. An update for clinicians.

Pellicano R, Mladenova I, Dimitrova SM, Bruno CM, Sciacca C, Rizzetto M.

Minerva Gastroenterol Dietol. 2004 Mar;50(1):1-7. Review.

PMID:
15719001
16.

A four-year review of patients with hepatitis C antibody in Department of Veterans Affairs facilities.

Roselle GA, Danko LH, Mendenhall CL.

Mil Med. 1997 Nov;162(11):711-4.

PMID:
9358714
17.

Global burden of disease (GBD) for hepatitis C.

Global Burden Of Hepatitis C Working Group.

J Clin Pharmacol. 2004 Jan;44(1):20-9. Review.

PMID:
14681338
18.

The epidemiology and natural history of hepatitis C virus infection.

Zein NN.

Cleve Clin J Med. 2003 Sep;70 Suppl 4:S2-6. Review.

PMID:
14558639
19.

Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.

Nainan OV, Alter MJ, Kruszon-Moran D, Gao FX, Xia G, McQuillan G, Margolis HS.

Gastroenterology. 2006 Aug;131(2):478-84.

PMID:
16890602
20.

Understanding hepatitis C.

McHutchison JG.

Am J Manag Care. 2004 Mar;10(2 Suppl):S21-9. Review.

Supplemental Content

Support Center